PROSTEP Drug Patent Profile

✉ Email this page to a colleague

When do Prostep patents expire, and what generic alternatives are available?

Prostep is a drug marketed by Aveva and is included in one NDA.

The generic ingredient in PROSTEP is nicotine. There are thirty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the nicotine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Prostep

A generic version of PROSTEP was approved as nicotine by DIFGEN PHARMS on October 20^th, 1997.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PROSTEP?
What are the global sales for PROSTEP?
What is Average Wholesale Price for PROSTEP?

Summary for PROSTEP

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	105
Patent Applications:	4,137
DailyMed Link:	PROSTEP at DailyMed

Drug patent expirations by year for PROSTEP

US Patents and Regulatory Information for PROSTEP

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aveva	PROSTEP	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	019983-003	Dec 23, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aveva	PROSTEP	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	019983-004	Dec 23, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PROSTEP

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aveva	PROSTEP	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	019983-003	Dec 23, 1998	⤷ Sign Up	⤷ Sign Up
Aveva	PROSTEP	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	019983-004	Dec 23, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PROSTEP

See the table below for patents covering PROSTEP around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
South Africa	8803081		⤷ Sign Up
Japan	S646216	THERAPY FOR ABSTINENCE SYMPTOM RELATED TO NO SMOKING AND MEDICINE THEREFOR	⤷ Sign Up
Canada	1333051	METHODE DE TRAITEMENT DES SYMPTOMES DE SEVRAGE LIES A L'ABANDON DU TABAC ET PREPARATIONS UTILISEES A CETTE FIN (METHOD FOR THE TREATMENT OF WITHDRAWAL SYMPTOMS ASSOCIATED WITH SMOKING CESSATION AND PREPARATIONS FOR USE IN SAID METHOD)	⤷ Sign Up
Israel	86170	PREPARATIONS AND COMPOSITIONS COMPRISING NICOTINE FOR PERCUTANEOUS ADMINISTRATION	⤷ Sign Up
Greece	3026563		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PROSTEP

Make Better Decisions: Try a trial or see plans & pricing